Literature DB >> 23053737

Close intramolecular sulfur-oxygen contacts: modified force field parameters for improved conformation generation.

Dmitry Lupyan1, Yuriy A Abramov, Woody Sherman.   

Abstract

The Cambridge Structural Database (CSD) offers an excellent data source to study small molecule conformations and molecular interactions. We have analyzed 130 small molecules from the CSD containing an intramolecular sulfur-oxygen distance less than the sum of their van der Waals (vdW) radii. Close S···O distances are observed in several important medicinal chemistry motifs (e.g. a carbonyl oxygen connected by a carbon or nitrogen linker to a sulfur) and are not treated well with existing parameters in the MMFFs or OPLS_2005 force fields, resulting in suboptimal geometries and energetics. In this work, we develop modified parameters for the OPLS_2005 force field to better treat this specific interaction in order to generate conformations close to those found in the CSD structures. We use a combination of refitting a force field torsional parameter, adding a specific atom pair vdW term, and attenuating the electrostatic interactions to obtain an improvement in the accuracy of geometry minimizations and conformational searches for these molecules. Specifically, in a conformational search 58 % of the cases produced a conformation less than 0.25 Å from the CSD crystal conformation with the modified OPLS force field parameters developed in this work. In contrast, 25 and 37 % produced a conformation less than 0.25 Å with the MMFFs and OPLS_2005 force fields, respectively. As an application of the new parameters, we generated conformations for the tyrosine kinase inhibitor axitinib (trade name Inlyta) that could be correctly repacked into three observed polymorphic structures, which was not possible with conformations generated using MMFFs or OPLS_2005. The improved parameters can be mapped directly onto physical characteristics of the systems that are treated inadequately with the molecular mechanics force fields used in this study and potentially other force fields as well.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053737     DOI: 10.1007/s10822-012-9610-x

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  28 in total

Review 1.  Drug polymorphism and dosage form design: a practical perspective.

Authors:  Dharmendra Singhal; William Curatolo
Journal:  Adv Drug Deliv Rev       Date:  2004-02-23       Impact factor: 15.470

2.  Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field.

Authors:  Devleena Shivakumar; Joshua Williams; Yujie Wu; Wolfgang Damm; John Shelley; Woody Sherman
Journal:  J Chem Theory Comput       Date:  2010-04-14       Impact factor: 6.006

3.  Sulfonamide-related conformational effects and their importance in structure-based design.

Authors:  Stefan Senger; Chuen Chan; Máire A Convery; Julia A Hubbard; Gita P Shah; Nigel S Watson; Robert J Young
Journal:  Bioorg Med Chem Lett       Date:  2007-02-16       Impact factor: 2.823

Review 4.  CHARMM: the biomolecular simulation program.

Authors:  B R Brooks; C L Brooks; A D Mackerell; L Nilsson; R J Petrella; B Roux; Y Won; G Archontis; C Bartels; S Boresch; A Caflisch; L Caves; Q Cui; A R Dinner; M Feig; S Fischer; J Gao; M Hodoscek; W Im; K Kuczera; T Lazaridis; J Ma; V Ovchinnikov; E Paci; R W Pastor; C B Post; J Z Pu; M Schaefer; B Tidor; R M Venable; H L Woodcock; X Wu; W Yang; D M York; M Karplus
Journal:  J Comput Chem       Date:  2009-07-30       Impact factor: 3.376

5.  QTAIM application in drug development: prediction of relative stability of drug polymorphs from experimental crystal structures.

Authors:  Yuriy A Abramov
Journal:  J Phys Chem A       Date:  2011-09-22       Impact factor: 2.781

6.  Attractive through-space S-O interaction in the DNA-cleaving antitumor antibiotic leinamycin.

Authors:  S Wu; A Greer
Journal:  J Org Chem       Date:  2000-08-11       Impact factor: 4.354

7.  Accurate Calculation of Hydration Free Energies using Pair-Specific Lennard-Jones Parameters in the CHARMM Drude Polarizable Force Field.

Authors:  Christopher M Baker; Pedro E M Lopes; Xiao Zhu; Benoît Roux; Alexander D Mackerell
Journal:  J Chem Theory Comput       Date:  2010-03-01       Impact factor: 6.006

8.  Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate.

Authors:  Y Kobayashi; S Ito; S Itai; K Yamamoto
Journal:  Int J Pharm       Date:  2000-01-05       Impact factor: 5.875

9.  ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.

Authors:  D J Kempf; K C Marsh; J F Denissen; E McDonald; S Vasavanonda; C A Flentge; B E Green; L Fino; C H Park; X P Kong
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

10.  Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.

Authors:  Ezra E W Cohen; Lee S Rosen; Everett E Vokes; Merrill S Kies; Arlene A Forastiere; Francis P Worden; Madeleine A Kane; Eric Sherman; Sinil Kim; Paul Bycott; Michael Tortorici; David R Shalinsky; Katherine F Liau; Roger B Cohen
Journal:  J Clin Oncol       Date:  2008-06-09       Impact factor: 44.544

View more
  3 in total

1.  Improved Description of Sulfur Charge Anisotropy in OPLS Force Fields: Model Development and Parameterization.

Authors:  Xin Cindy Yan; Michael J Robertson; Julian Tirado-Rives; William L Jorgensen
Journal:  J Phys Chem B       Date:  2017-06-29       Impact factor: 2.991

2.  Searching for bioactive conformations of drug-like ligands with current force fields: how good are we?

Authors:  Oya Gürsoy; Martin Smieško
Journal:  J Cheminform       Date:  2017-05-15       Impact factor: 5.514

3.  Accuracy evaluation and addition of improved dihedral parameters for the MMFF94s.

Authors:  Joel Wahl; Joel Freyss; Modest von Korff; Thomas Sander
Journal:  J Cheminform       Date:  2019-08-07       Impact factor: 5.514

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.